Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity
Keisuke Yanagida, … , Satoshi Ishii, Takao Shimizu
Keisuke Yanagida, … , Satoshi Ishii, Takao Shimizu
Published December 20, 2018
Citation Information: JCI Insight. 2018;3(24):e97293. https://doi.org/10.1172/jci.insight.97293.
View: Text | PDF
Research Article Metabolism

The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity

  • Text
  • PDF
Abstract

White adipose tissue (WAT) can dynamically expand and remodel through adipocyte hypertrophy and hyperplasia. The relative contribution of these 2 mechanisms to WAT expansion is a critical determinant of WAT function and dysfunction in obesity. However, little is known about the signaling systems that determine the mechanisms of WAT expansion. Here, we show that the GPCR LPA4 selectively activates Gα12/13 proteins in adipocytes and limits continuous remodeling and healthy expansion of WAT. LPA4-KO mice showed enhanced expression of mitochondrial and adipogenesis genes and reduced levels of inhibitory phosphorylation of PPARγ in WAT, along with increased production of adiponectin. Furthermore, LPA4-KO mice showed metabolically healthy obese phenotypes in a diet-induced obesity model, with continuous WAT expansion, as well as protection from WAT inflammation, hepatosteatosis, and insulin resistance. These findings unravel a potentially new signaling system that underlies WAT plasticity and expandability, providing a promising therapeutic approach for obesity-related metabolic disorders.

Authors

Keisuke Yanagida, Hidemitsu Igarashi, Daisuke Yasuda, Daiki Kobayashi, Takayo Ohto-Nakanishi, Noriyuki Akahoshi, Atsushi Sekiba, Tsudoi Toyoda, Tomoko Ishijima, Yuji Nakai, Nobuhiro Shojima, Naoto Kubota, Keiko Abe, Takashi Kadowaki, Satoshi Ishii, Takao Shimizu

×

Figure 2

LPA4 selectively activates Gα12/13 protein in C3H10T1/2- and mouse embryonic fibroblast–derived (MEF-derived) adipocytes.

Options: View larger image (or click on image) Download as PowerPoint
LPA4 selectively activates Gα12/13 protein in C3H10T1/2- and mouse embry...
(A) Top, schematic of the assay system for predominant activation of LPA4 with octadecenyl phosphate (ODP) in the presence of Ki16425. Middle and bottom, ethidium bromide–stained agarose gels of reverse transcription PCR (RT-PCR) products of expressed LPA receptors in C3H10T1/2-derived (middle) and MEF-derived (bottom) adipocytes. (B and C) Effects of ODP (2.5 μM) on intracellular cAMP levels in C3H10T1/2-derived adipocytes (n = 4). Isoproterenol (ISOP, 10 μM) and lactic acid (30 mM) were used as positive controls for Gαs (B) and Gαi (C) protein activation, respectively. (D) A representative chart recording of intracellular Ca2+ level in C3H10T1/2-derived adipocytes upon stimulation with ODP (1 μM). Endothelin-1 (ET-1, 100 nM) was used as a positive control for Gαq protein activation. (E) Effects of ODP and siRNA against LPA4 or Gα12/13 on serum response factor–responsive element (SRF-RE) luciferase activity in C3H10T1/2-derived adipocytes (n = 4). (F) Effects of Rho and ROCK inhibition by Rho inhibitor I (2 μg/ml) and Y27632 (10 μM), respectively, on ODP-induced SRF-RE luciferase activity in C3H10T1/2-derived adipocytes (n = 4). (G and H) Effects of ODP (1 μM) on intracellular cAMP levels in MEF-derived adipocytes (n = 4). Isoproterenol (ISOP, 10 μM) and lactic acid (30 mM) were used as positive controls for Gαs (G) and Gαi (H) protein activation, respectively. (I) A representative chart recording of intracellular Ca2+ level in MEF-derived adipocytes upon stimulation with ODP (1 μM). Endothelin-1 (ET-1, 100 nM) was used as a positive control for Gαq protein activation. (J) Effects of ODP (1 μM) on SRF-RE luciferase activity in MEF-derived adipocytes isolated from WT and Lpar4-KO mice (n = 4). Results are representative of at least 3 independent experiments. Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; 1-way ANOVA with Bonferroni’s (E and F) or Dunnett’s (B,C,G,H) post hoc test, and unpaired Student’s t test (J) were used.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts